Exchange: NASDAQ·Updated 03:45 AM EDT
ABCL logo

ABCLAbCellera Biologics Inc

$5.85
$0.16
(2.81%)
Overnight
Prev Close $5.69
EarningsAug 5
Mkt Cap$1.65B
Vol4.34M
Upcoming Earnings: Q2 '26

Reports: Aug 05After Hours

Estimated EPS

-$0.14

Estimated Rev

$7.85M

$ABCL Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.14 up 6.67% YoY • Reported revenue of $8.31M up 96.34% YoY

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q2 '26
-$0.14
--
--
N/A
Q1 '26
-$0.17
-$0.14
18.33%
BEAT
Q4 '25
-$0.13
-$0.03
77.61%
BEAT
Q3 '25
-$0.14
-$0.19
-36.94%
MISSED
Q2 '25
-$0.13
-$0.12
10.56%
BEAT

Advertisement|Remove ads.